Hebei Junlin Pharmaceutical Co., Ltd.

Hebei Junlin Pharmaceutical Co., Ltd. was established in August 2000, with more than 800 employees. It is a modern private pharmaceutical manufacturing enterprise integrating R&D, production, processing and sales. The company's business scope involves the production, processing, and sales of dosage forms and products such as mixtures, glues, tablets, hard capsules, granules, and APIs. The exclusive products include aloe vera pearl capsules, donkey-hide gelatin and astragalus oral liquid, nitrendipine dispersible tablets, etc. It also includes donkey-hide gelatin, deer antler glue, tortoise shell glue, donkey-hide gelatin granules, isatis root granules, traditional Chinese medicine pieces and other series of products. The company has a complete and scientific management system, strong technical force, and complete supporting facilities. Over the past 20 years of operation, the company has adhered to people-oriented, good-rooted, contract-abiding, and trustworthy, winning the trust of our customers and achieving good economic and social benefits. Through continuous development in the past 20 years, the company has successively won the titles of "Hebei Province Leading Poverty Alleviation Enterprise", "Hebei Province High-tech Enterprise", "Hebei Province Top 100 Leading Companies in Strategic Emerging Industries in 2017" and other titles. The "Junlin" trademark was recognized as a "China Famous Trademark", and the "Junlin" brand won the title of "Hebei Business Card". The company's R&D center has been approved and recognized as "Hebei Province Traditional Chinese Medicine Oral Preparation Process Engineering Technology Research Center", "Hebei Province Enterprise Technology Center", and "A-level Hebei Province Industrial Enterprise R&D Institution". The exclusive products Aloe Vera Pearl Capsule and Donkey-hide Gelatin Astragalus Oral Liquid won the "Gold Medal of the 10th China Patented High-tech Products Expo", national invention patent and national new drug certificate, etc. Looking to the future,